Alphalyse A/S

What to expect? | Thomas Kofoed, CEO at Alphalyse

With ELISA-MS you don't need a null cell line to get the HCP coverage number

USP 1132.1 - New US Pharmacopeia chapter on residual HCP measurement in Biopharmaceuticals by MS

Moving LC-MS HCP analysis into a GMP environment

Hitchhiker HCP - a common reason for ELISA validation problems

Protein analysis for upscaling of batches | Biologics development | HCP ELISA assays

HCP characterization and process development | Genmab off-ELISA strategy webinar part 1

S1E06: Solving the HCP puzzle with mass spectrometry | Rewrite the Rules [FULL]

Host cell protein quantification in 6 step purification process

Convincing documentation of HCP Clearance in PPQ runs | Host Cell Protein Quantification

Removal of HCPs based on LC-MS data | Alphalyse

HCP characterization of in-process samples | Genmab webinar Part 1

Host Cell Protein purification optimization - from harvest to final DS | HCP analysis

Host Cell Protein (HCP) analysis for biologics purification